Has the Japanese Life Sciences Industry valuation changed over the past few years?
|Thu, 27 Jan 2022||JP¥232.4b||JP¥136.0b||JP¥6.8b||19.5x|
|Sat, 25 Dec 2021||JP¥286.6b||JP¥136.0b||JP¥6.8b||23.5x|
|Mon, 22 Nov 2021||JP¥349.8b||JP¥135.7b||JP¥6.9b||28.1x|
|Wed, 20 Oct 2021||JP¥375.1b||JP¥198.7b||JP¥8.1b||25.9x|
|Fri, 17 Sep 2021||JP¥378.1b||JP¥198.4b||JP¥7.9b||25.6x|
|Sun, 15 Aug 2021||JP¥355.8b||JP¥201.8b||JP¥5.0b||25.9x|
|Thu, 10 Jun 2021||JP¥321.0b||JP¥194.0b||JP¥2.5b||29.5x|
|Wed, 03 Mar 2021||JP¥287.0b||JP¥191.7b||JP¥152.2m||30.2x|
|Sat, 05 Dec 2020||JP¥284.8b||JP¥190.0b||-JP¥434,535,000.00||47.9x|
|Tue, 08 Sep 2020||JP¥307.2b||JP¥189.8b||JP¥2.0b||18.3x|
|Mon, 01 Jun 2020||JP¥296.6b||JP¥193.4b||JP¥2.7b||22.1x|
|Thu, 05 Mar 2020||JP¥207.1b||JP¥190.2b||JP¥1.9b||20x|
|Sun, 08 Dec 2019||JP¥256.0b||JP¥187.0b||JP¥2.1b||37.6x|
|Sat, 31 Aug 2019||JP¥213.0b||JP¥184.1b||JP¥1.5b||30.5x|
|Tue, 04 Jun 2019||JP¥234.6b||JP¥181.6b||JP¥1.3b||17.8x|
|Fri, 08 Mar 2019||JP¥258.3b||JP¥180.0b||-JP¥879,502,000.00||21.9x|
Current Industry PE: Investors are more pessimistic on the industry, considering it's trading at a PE ratio of 19.5x which is lower than its 3-year average PE of 27.1x. It appears they believe that earnings will not grow as fast as they have historically.
Past Earnings Growth: Total earnings for the Life Sciences industry have gone up over the last three years, and the industry is now profitable. However revenues have declined 8.9% per year. This means that less sales are being generated overall, but since the cost of doing business is lower, profits have been increasing.
Which industries have driven the changes within the Japanese Life Sciences industry?
|Clinical Research and Equipment||-3.71%|
Industry PE: Investors are most optimistic about the Clinical Research and Equipment industry even though it's trading below its 3-year average PE ratio of 27.1x. However analysts are expecting annual earnings growth of 32%, which is lower than the prior year's growth of 187% per year. So the market might believe that analysts are underestimating future growth.
Forecasted Growth: Analysts are most optimistic on the Clinical Research and Equipment industry, expecting annual earnings growth of 32% over the next 5 years. However this is lower than its past earnings growth rate of 187% per year.
Which companies have driven the market over the last 7 days?
|2309 CMIC HOLDINGS||JP¥1.46k||2.9%|
|4583 Chiome Bioscience||JP¥174.00||5.5%|
|6090 Human Metabolome Technologies||JP¥581.00||0.3%|
|4570 Immuno-Biological Laboratories||JP¥343.00||0.3%|
Human Metabolome Technologies
Shin Nippon Biomedical Laboratories